Interleukin Inhibitors May Raise Infection, Cancer Risks
Categories
Treatment of rheumatologic diseases with interleukin inhibitors may raise patients’ risks for serious and opportunistic infections and possibly also cancer, researchers reported in JAMA Network Open in October.
https://www.rheumatologynetwork.com/news/interleukin-inhibitors-may-raise-infection-cancer-risks